- Home
- ZDGE vs SCLX Comparison
ZDGE vs SCLX Comparison
Compare ZDGE & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- SCLX
- Stock Information
- Founded
- ZDGE 2008
- SCLX 2011
- Country
- ZDGE United States
- SCLX United States
- Employees
- ZDGE N/A
- SCLX N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- SCLX Health Care
- Exchange
- ZDGE Nasdaq
- SCLX Nasdaq
- Market Cap
- ZDGE 44.4M
- SCLX 35.7M
- IPO Year
- ZDGE N/A
- SCLX N/A
- Fundamental
- Price
- ZDGE $3.14
- SCLX $12.78
- Analyst Decision
- ZDGE
- SCLX Buy
- Analyst Count
- ZDGE 0
- SCLX 2
- Target Price
- ZDGE N/A
- SCLX $245.00
- AVG Volume (30 Days)
- ZDGE 41.1K
- SCLX 294.8K
- Earning Date
- ZDGE 10-29-2025
- SCLX 08-13-2025
- Dividend Yield
- ZDGE N/A
- SCLX N/A
- EPS Growth
- ZDGE N/A
- SCLX N/A
- EPS
- ZDGE N/A
- SCLX N/A
- Revenue
- ZDGE $29,511,000.00
- SCLX $44,236,000.00
- Revenue This Year
- ZDGE N/A
- SCLX $89.26
- Revenue Next Year
- ZDGE $2.95
- SCLX $203.95
- P/E Ratio
- ZDGE N/A
- SCLX N/A
- Revenue Growth
- ZDGE 1.27
- SCLX N/A
- 52 Week Low
- ZDGE $1.73
- SCLX $3.60
- 52 Week High
- ZDGE $4.89
- SCLX $39.90
- Technical
- Relative Strength Index (RSI)
- ZDGE 49.17
- SCLX 33.57
- Support Level
- ZDGE $3.11
- SCLX $14.80
- Resistance Level
- ZDGE $3.35
- SCLX $15.25
- Average True Range (ATR)
- ZDGE 0.17
- SCLX 2.44
- MACD
- ZDGE 0.02
- SCLX -0.99
- Stochastic Oscillator
- ZDGE 43.01
- SCLX 1.60
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.